Home
>
National Drug Code (NDC)
>
Atripla
Atripla - 24236-292-22 - (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
Drug Information of Atripla
| Product NDC: | 24236-292 |
| Proprietary Name: | Atripla |
| Non Proprietary Name: | efavirenz, emtricitabine, and tenofovir disoproxil fumarate |
| Active Ingredient(s): | 600 mg/1 & nbsp; efavirenz, emtricitabine, and tenofovir disoproxil fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atripla
| Product NDC: | 24236-292 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021937 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130329 |
Package Information of Atripla
| Package NDC: | 24236-292-22 |
| Package Description: | 150 TABLET, FILM COATED in 1 CANISTER (24236-292-22) |
NDC Information of Atripla
| NDC Code | 24236-292-22 |
| Proprietary Name | Atripla |
| Package Description | 150 TABLET, FILM COATED in 1 CANISTER (24236-292-22) |
| Product NDC | 24236-292 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | efavirenz, emtricitabine, and tenofovir disoproxil fumarate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130329 |
| Marketing Category Name | NDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | EFAVIRENZ |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
